2.00

5.09% -0.1072

After Hours: 2.11 0.11 +5.50%

BioAffinity Technologies Inc (BIAF)

Overview News Price History Financials Discussions Forecast

BioAffinity Technologies Inc stock is currently priced at $2.00, with a 24-hour trading volume of 72,040. It has seen a -5.09% decreased in the last 24 hours and a +6.95% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $2.10 pivot point. If it approaches the $1.95 support level, significant changes may occur.

Previous Close:

$2.1072

Open:

$1.93

24h Volume:

72,040

Market Cap:

$22.72M

Revenue:

$321.50K

Net Income/Loss:

$-7.24M

P/E Ratio:

-1.143

EPS:

-1.7498

Net Cash Flow:

$-5.72M

1W Performance:

-13.04%

1M Performance:

+6.95%

6M Performance:

+38.89%

1Y Performance:

+14.94%

1D Range:

$1.93

$2.11

52W Range:

$0.9548

$3.62

BioAffinity Technologies Inc Stock (BIAF) Company Profile

Name

BioAffinity Technologies Inc

Sector

Healthcare (1204)

Industry

Diagnostics & Research (68)

Phone

210 698 5334

Address

22211 West Interstate 10, Suite 1206, San Antonio

Employee

Twitter

Next Earnings Date

Latest SEC Filings

BIAF's Discussions on Twitter

BioAffinity Technologies Inc Stock (BIAF) Latest News

bioAffinity Technologies, Inc. (NASDAQ:BIAFW) Short Interest Update - Defense World

Defense World

bioAffinity Technologies Shareholders Back Future Growth Plans - TipRanks.com - TipRanks

TipRanks

Short Interest in bioAffinity Technologies, Inc. (NASDAQ:BIAF) Rises By 7.1% - Defense World

Defense World

BioAffinity Technologies Inc (BIAF)'s Ratio Roundup: Key Metrics for Trailing Twelve Months – DWinneX - The Dwinnex

The Dwinnex

bioAffinity Technologies earnings missed by $0.02, revenue topped estimates - Investing.com South Africa

Investing.com South Africa

bioAffinity Technologies GAAP EPS of -$0.21, revenue of $2.4M - Seeking Alpha

Seeking Alpha

BioAffinity Technologies Inc Stock (BIAF) Financials Data

BioAffinity Technologies Inc (BIAF) Revenue 2024

BIAF reported a revenue (TTM) of $321.50 thousand for the quarter ending September 30, 2023.

BioAffinity Technologies Inc (BIAF) Net Income 2024

BIAF net income (TTM) was -$7.24 million for the quarter ending September 30, 2023, a +39.96% increase year-over-year.

BioAffinity Technologies Inc (BIAF) Cash Flow 2024

BIAF recorded a free cash flow (TTM) of -$5.72 million for the quarter ending September 30, 2023, a -67.19% decrease year-over-year.

BioAffinity Technologies Inc (BIAF) Earnings per Share 2024

BIAF earnings per share (TTM) was -$0.8398 for the quarter ending September 30, 2023, a +77.82% growth year-over-year.

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.